Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients-Reference-Cited by-同舟云学术

Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients

Published:2017-03-10 Issue:9 Volume:17 Page:2381-2389
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Choi J.¹,Aubert O.²,Vo A.¹,Loupy A.²,Haas M.³,Puliyanda D.¹,Kim I.¹,Louie S.¹,Kang A.¹,Peng A.¹,Kahwaji J.¹,Reinsmoen N.³,Toyoda M.⁴,Jordan S. C.¹

Affiliation:

1. Comprehensive Transplant Center; Cedars-Sinai Medical Center; Los Angeles CA

2. Paris Translational Research Center for Organ Transplantation; INSERM U970; Biostatistics Department; Paris France

3. Department of Pathology; Cedars-Sinai Medical Center; Los Angeles CA

4. HLA Laboratory; Cedars-Sinai Medical Center; Los Angeles CA

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14228/fullpdf

Reference37 articles.

1. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis;Colvin;J Am Soc Nephrol,2007

2. Diagnosis and management of antibody-mediated rejection: Current status and novel approaches;Djamali;Am J Transplant,2014

3. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial;Jordan;J Am Soc Nephrol,2004

4. Desensitization protocols and their outcome;Marfo;Clin J Am Soc Nephrol,2011

5. Desensitization in HLA-incompatible kidney recipients and survival;Montgomery;N Engl J Med,2011

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Tocilizumab in the treatment of chronic active antibody-mediated rejection in pediatric kidney transplant recipients;Human Immunology;2024-09

2. Coronavirus Disease 2019 in Kidney Transplantation – A 2024 Update;Advances in Kidney Disease and Health;2024-09

3. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

4. A Population Pharmacokinetic Model of Tocilizumab in Kidney Transplant Patients Treated for Chronic Active Antibody-Mediated Rejection: Comparison of Plasma Exposure Between Intravenous and Subcutaneous Administration Schemes;BioDrugs;2024-08-15

5. Antibody-Mediated Rejection in Lung Transplantation: Diagnosis and Therapeutic Armamentarium in a 21st Century Perspective;Transplant International;2024-08-07